EFLUELDA

This brand name is authorized in Austria, Spain, Croatia, Ireland, Israel, Poland, Romania

Active ingredients

The drug EFLUELDA contains a combination of these active pharmaceutical ingredients (APIs):

1 A/Victoria/4897/2022 (H1N1)pdm09-like strain (A/Victoria/4897/2022, IVR-238)

Read about Influenza, inactivated, split virus

2 A/Darwin/9/2021 (H3N2)-like strain (A/Darwin/9/2021, SAN-010)

Read about Influenza, inactivated, split virus

3 B/Austria/1359417/2021-like strain (B/Michigan/01/2021, wild type)

Read about Influenza, inactivated, split virus

4 B/Phuket/3073/2013-like strain (B/Phuket/3073/2013, wild type)

Read about Influenza, inactivated, split virus

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
J07BB02	Influenza, purified antigen	J Antiinfectives for systemic use → J07 Vaccines → J07B Viral vaccines → J07BB Influenza vaccines
Discover more medicines within J07BB02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 85068
Country: IL	מִשְׂרַד הַבְּרִיאוּת	Identifier(s): 9135
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100421170
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W66869001, W66869002, W66869003, W66869004, W66869005, W66869006